Physiologically based pharmacokinetic modeling of tapentadol in children to support pediatric dose selection
- 9 May 2025
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 114 (7) , 103830
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82204527)
- Anhui Provincial Natural Science Foundation (2208085QH279)
This publication has 57 references indexed in Scilit:
- In‐Depth Analysis of the Selection of PBPK Modeling Tools: Bibliometric and Social Network Analysis of the Open Systems Pharmacology CommunityThe Journal of Clinical Pharmacology, 2024
- Develop adult extrapolation to pediatrics and pediatric dose optimization based on the physiological pharmacokinetic model of azithromycinBiopharmaceutics & Drug Disposition, 2023
- Physiologically Based Pharmacokinetic Modeling of Oxycodone in Children to Support Pediatric Dosing OptimizationPharmaceutical Research, 2019
- Effects of Rolapitant Administered Intravenously on the Pharmacokinetics of a Modified Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan) in Healthy SubjectsThe Journal of Clinical Pharmacology, 2018
- Comparative pharmacology and toxicology of tramadol and tapentadolEuropean journal of pain, 2018
- On the Molecular Basis Underlying the Metabolism of Tapentadol Through SulfationEuropean Journal of Drug Metabolism and Pharmacokinetics, 2017
- Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenClinical Pharmacokinetics, 2015
- Paediatric drug development: The impact of evolving regulationsAdvanced Drug Delivery Reviews, 2014
- Absorption, metabolism, and excretion of14C-labeled Tapentadol HCl in healthy male subjectsEuropean Journal of Drug Metabolism and Pharmacokinetics, 2007
- Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterionsJournal of Pharmaceutical Sciences, 2006